Kelly Dyer, MD
Infectious Diseases
Accepting new patients
Sees patients age 18 and up
MacGregor Infection Medicine and Travel Program
View 1 additional location
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Medicine (Infectious Diseases)

Education and training

  • Medical School: Emory University
  • Residency: Emory University
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Dyer is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Kelly Dyer Substance Use Disorder and HIV/AIDS: Addressing Dual Crises [Interview] , American Journal of Managed Care: 2024


Dyer K, Sabetan S, Bourbeau M, Yang W-T, Torgerson J, Aitcheson N Integration of comprehensive infectious disease screening within an inpatient detoxification unit in Philadelphia: Capitalizing on engagement opportunities to reduce harm and improve patient outcomes , 25th International AIDS Conference: 2024


Leekha S, Robinson G.L, Jacob J.T, Fridkin S, Shane A, Sick-Samuels A, Milstone AM, Nair R, Perencevich E, Puig-Asensio M, Kobayashi T, Mayer J, Lewis J, Bleasdale S, Wenzler E, Mena Lora AJ, Baghdadi J, Schrank GM, Wilber E, Aldredge AA, Sharp J, Dyer KE, Kendrick L, Ambalam V, Borgetti S, Carmack A, Gushiken A, Patel A, Reddy S, Brown CH, Dantes RB, Harris AD Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study , BMJ Quality and Safety, 8: 2024,487-498


Dyer K, Russel R, Nafiz R, Burdick-McPhee A, O’Neal J, Mason T, Kuncio D, Zellman H, Lo Re V, Torgersen J Opt-Out Infectious Disease Screening within an Inpatient Substance Use Treatment Program: Opportunities for Infection Prevention and Expedited Care , oral presentation at The 12th International Conference on Health and Hepatitis in Substance Users: 2024


Loeven N, Altneu E, Spivack S, Halpern-Cohen V, Dyer K, Sullivan K, Epstein S, Teixera da Silva D, Meisner J, Schultz S Increase in iGAS seen at two urban quaternary care centers in Philadelphia: Association with PWID and the unstably housed , ID Week: 2023


Jones MD, Dyer K, Nedell ER, Fletcher MR, Grimsley Ackerley C, Hussen SA, Kalokhe AS One size does not fit all: Preferences for HIV care delivery among out-of-care people living with HIV in the Southeastern United States , PloS One, 18(1): 2023


Loeven N, Dyer K, Halpern-Cohen V, Comar C, Meisner J, Glaser L Macrolide and lincosamide susceptibility profiles and use of clindamycin for iGAS in one hospital in Philadelphia , ASM Microbe: 2023


Dyer KE, Jones MD, Fletcher MR, Grimsley Ackerly C, Hussen SA, Nedell ER, Kalokhe AS One Size Does Not Fit All: Preferences for HIV Care Delivery Among Out-of-Care People Living with HIV in the United States , 11th International AIDS Society Conference on HIV Science: 2021


Dyer K, del Rio C, Colasanti J Provider Experience with Implementation and Delivery of Pre-Exposure Prophylaxis (PrEP) in Clinical Practice: A Survey of Atlanta’s HIV Providers , SGIM Southern Regional Conference: 2021


Dyer K, Vettese TE Unexplained Symptomatic Paroxysmal Hypertension: a Diagnostic and Management Challenge , J Gen Intern Med, 35(2): 2020,e0276852